BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1078-1087 [PMID: 26811648 DOI: 10.3748/wjg.v22.i3.1078]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1078.htm
(419) (403) (0) (0) (21710) (242)
Number Citing Articles
1
Junlin Xie, Shanshan Deng, Xianqin Zhang, Lin Zhang, Xu Jia. From dysbacteriosis to ecological remodeling: A new breakthrough in microbial treatment of inflammatory bowel disease. iScience 2026; 29(5) doi: 10.1016/j.isci.2026.115483
2
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244 doi: 10.1016/j.ijbiomac.2023.125472
3
Ying Liu, Hao Ai. Current research update on group B streptococcal infection related to obstetrics and gynecology. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1395673
4
Xia Chen, Hongming Li, Guang Wang, Zhenxing Wang, Yan Lv, Hui Xie, Sheng Zhu. Exploring the role of intestinal pathogenic bacteria in metronidazole-induced bone loss: focus on Klebsiella variicola. Gut Pathogens 2025; 17(1) doi: 10.1186/s13099-025-00713-4
5
Kaitlyn Oliphant, Kyla Cochrane, Kathleen Schroeter, Michelle C. Daigneault, Sandi Yen, Elena F. Verdu, Emma Allen-Vercoe, Pieter C. Dorrestein. Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro . mSystems 2020; 5(1) doi: 10.1128/msystems.00404-19
6
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine. 2018;  doi: 10.1007/978-3-319-28100-1_9-1
7
J. Garrido-Mesa, F. Algieri, A. Rodríguez-Nogales, T. Vezza, M.P. Utrilla, F. Garcia, N. Chueca, M.E. Rodríguez-Cabezas, N. Garrido-Mesa, J. Gálvez. Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition. Biochemical Pharmacology 2018; 155 doi: 10.1016/j.bcp.2018.07.044
8
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann, Nazila Kamaly. Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 2022;  doi: 10.1016/j.smim.2022.101664
9
Yousra M. El-Far, Nehal M. Elsherbiny, Mohamed El-Shafey, Eman Said. The interplay of the inhibitory effect of nifuroxazide on NF-κB/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats. Environmental Toxicology and Pharmacology 2020; 79 doi: 10.1016/j.etap.2020.103433
10
Hemanta Koley, Debaki Ranjan Howlader, Ushasi Bhaumik. New Look to Phytomedicine. 2019;  doi: 10.1016/B978-0-12-814619-4.00022-7
11
Nikoo Hossein-khannazer, Shukoofeh Torabi, Ramin Hosseinzadeh, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Arash Memarnejadian, Nadir Kadri, Massoud Vosough. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Human Cell 2021; 34(5) doi: 10.1007/s13577-021-00560-w
12
Jillian S Y Lau, Tony M Korman, Ian Woolley. Life-long antimicrobial therapy: where is the evidence?. Journal of Antimicrobial Chemotherapy 2018; 73(10) doi: 10.1093/jac/dky174
13
Luis Vitetta, Debbie Oldfield, Avni Sali. Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods. Frontiers in Bioscience-Elite 2024; 16(2) doi: 10.31083/j.fbe1602013
14
Jay Fuerte-Stone, Mark Mimee. Host happy hour: Phage cocktail targets IBD-associated microbes. Cell Host & Microbe 2022; 30(10) doi: 10.1016/j.chom.2022.09.010
15
Yuechi Fu, Heng-Wei Cheng. The Influence of Cecal Microbiota Transplantation on Chicken Injurious Behavior: Perspective in Human Neuropsychiatric Research. Biomolecules 2024; 14(8) doi: 10.3390/biom14081017
16
Sofia Moran-Ramos, Blanca E. López-Contreras, Samuel Canizales-Quinteros. Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?. Archives of Medical Research 2017; 48(8) doi: 10.1016/j.arcmed.2017.11.003
17
Maijian Wang, Yong Li, Xuefeng Yang, Zhenxing Liu, Kai Wang, Dengmei Gong, Jida Li. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice. Immunity, Inflammation and Disease 2023; 11(11) doi: 10.1002/iid3.1067
18
Maria Elaine Araruna, Catarina Serafim, Edvaldo Alves Júnior, Clelia Hiruma-Lima, Margareth Diniz, Leônia Batista. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010–2020): A Review. Molecules 2020; 25(22) doi: 10.3390/molecules25225430
19
Bobby Lo, Luc Biederman, Gerhard Rogler, Barbara Dora, Andrea Kreienbühl, Ida Vind, Flemming Bendtsen, Johan Burisch. Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study. Journal of Crohn's and Colitis 2024; 18(8) doi: 10.1093/ecco-jcc/jjae027
20
Amir Barkhodari, Kate E. Lee, Min Shen, Bo Shen, Qingping Yao. Inflammatory bowel disease: focus on enteropathic arthritis and therapy. Rheumatology and Immunology Research 2022; 3(2) doi: 10.2478/rir-2022-0012
21
Francesca Gorini, Alessandro Tonacci. Vitamin D: An Essential Nutrient in the Dual Relationship between Autoimmune Thyroid Diseases and Celiac Disease—A Comprehensive Review. Nutrients 2024; 16(11) doi: 10.3390/nu16111762
22
Wenshuo Chen, Haijin Chen, Shudan Fu, Xiaohua Lin, Zheng Zheng, Jinlong Zhang. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights. Bioprocess and Biosystems Engineering 2021; 44(5) doi: 10.1007/s00449-020-02380-y
23
Aline C. Fenneman, Melissa Weidner, Lea Ann Chen, Max Nieuwdorp, Martin J. Blaser. Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology 2023; 20(2) doi: 10.1038/s41575-022-00685-9
24
Nader Pestechian, Sanaz Tavakoli, Payman Adibi, Ahmad Hosseini Safa, Roghayeh Parsaei, Hossein Ali Yousefi. Prevalence of Intestinal Protozoan Infection in Patients with Ulcerative Colitis (UC) in Isfahan, Iran. International Journal of Preventive Medicine 2021; 12(1) doi: 10.4103/ijpvm.IJPVM_471_19
25
Nicolas Benech, Harry Sokol. Targeting the gut microbiota in inflammatory bowel diseases: where are we?. Current Opinion in Microbiology 2023; 74 doi: 10.1016/j.mib.2023.102319
26
Xiujing Zhang, Lizhuan Ma, Chao Zhang, Bingxu Hou, Yanli Zhou, Simiao Yu. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterología y Hepatología 2021; 44(9) doi: 10.1016/j.gastrohep.2020.10.008
27
Natasha Klemm, Sarvee Moosavi. Chronic Abdominal Pain in Patients with Inflammatory Bowel Disease in Remission: A Continuing Challenge for Clinicians. Digestive Diseases and Sciences 2024; 69(12) doi: 10.1007/s10620-024-08716-y
28
Naama Lang, Yana Davidov, Tomer Hoffman, Sivan Harnik, Abraham Rami Eliakim, Shomron Ben-Horin, Bella Ungar. Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review. Case Reports in Gastroenterology 2025; 19(1) doi: 10.1159/000544161
29
Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02015-w
30
Wimonrat Panpetch, Pornpimol Phuengmaung, Pratsanee Hiengrach, Jiraphorn Issara-Amphorn, Thanya Cheibchalard, Naraporn Somboonna, Somying Tumwasorn, Asada Leelahavanichkul. Candida Worsens Klebsiella pneumoniae Induced-Sepsis in a Mouse Model with Low Dose Dextran Sulfate Solution through Gut Dysbiosis and Enhanced Inflammation. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137050
31
Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis. Inflammatory Bowel Diseases 2021; 27(3) doi: 10.1093/ibd/izaa161
32
Denise B. Catacutan, Vian Tran, Autumn Arnold, Jeremie Alexander, Gabriele Corso, Yeganeh Yousefi, Megan M. Tu, Stewart McLellan, Dominique Tertigas, Kimberly Corneil, Jakob Magolan, Michael G. Surette, Eric D. Brown, Brian K. Coombes, Regina Barzilay, Jonathan M. Stokes. Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic. Nature Microbiology 2025; 10(11) doi: 10.1038/s41564-025-02142-0
33
Subrata Sabui, Jonathan Skupsky, Rubina Kapadia, Kyle Cogburn, Nils W. Lambrecht, Anshu Agrawal, Hamid M. Said. Tamoxifen-induced, intestinal-specific deletion of Slc5a6 in adult mice leads to spontaneous inflammation: involvement of NF-κB, NLRP3, and gut microbiota. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(4) doi: 10.1152/ajpgi.00172.2019
34
Mohammad E Farhad, Ibrahim Belal, Mohamed Baana, Caroline Childs, Moussa Al-Rufayie. Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission. Cureus 2025;  doi: 10.7759/cureus.96126
35
Megan T. Zangara, Lena Darwish, Brian K. Coombes, Alfredo G. Torres. Characterizing the Pathogenic Potential of Crohn’s Disease-Associated Adherent-Invasive Escherichia coli. EcoSal Plus 2023; 11(1) doi: 10.1128/ecosalplus.esp-0018-2022
36
Mahmoud Draidi, Ibtesam Abdullah, Shahem Abbarh, Jouhar Kolleri, Bisher Sawaf, Yaseen Alastal. Rare case of metronidazole‐induced encephalopathy in a multiple transplant recipient: Clinical and radiological insights. Clinical Case Reports 2025; 13(2) doi: 10.1002/ccr3.9544
37
Stefan Satka, Veronika Frybortova, Iveta Zapletalova, Pavel Anzenbacher, Eva Anzenbacherova, Hana Kozakova, Dagmar Srutkova, Tomas Hudcovic, Lenka Jourova. Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome. International Journal of Molecular Sciences 2022; 23(19) doi: 10.3390/ijms231911627
38
Zhen-Huan Yang, Fang Liu, Xiao-Ran Zhu, Fei-Ya Suo, Zi-jun Jia, Shu-Kun Yao. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World Journal of Gastroenterology 2021; 27(24): 3609-3629 doi: 10.3748/wjg.v27.i24.3609
39
Matthew Stephens, Keith Keane, Simon Roizes, Manon Defaye, Christophe Altier, Pierre-Yves von der Weid. Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease. Journal of Crohn's and Colitis 2025; 19(3) doi: 10.1093/ecco-jcc/jjaf032
40
Ivan Kushkevych, Michaela Dvořáková, Dani Dordevic, Bożena Futoma-Kołoch, Márió Gajdács, Lamiaa A. Al-Madboly, Mohamed Abd El-Salam. Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives. Computational and Structural Biotechnology Journal 2025; 27 doi: 10.1016/j.csbj.2025.02.026
41
Priscila R. Guerra, Fatemeh Ajalloueian, Shaodong Wei, Katja Ann Kristensen, Martin Iain Bahl, Anja Boisen, Tine Rask Licht. Delivery of streptomycin to the rat colon by use of electrospun nanofibers. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25769-z
42
Caroline Chevarin, Zhilu Xu, Lucas Martin, Frederic Robin, Racha Beyrouthy, Jean-Frédéric Colombel, Alexander Sulakvelidze, Siew C Ng, Richard Bonnet, Anthony Buisson, Nicolas Barnich. Comparison of Crohn’s disease-associated adherent-invasive Escherichia coli (AIEC) from France and Hong Kong: results from the Pacific study . Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2431645
43
Shangqing Zhang, Yan Chi, Hongfang Jin, Xiuli Wang, Xue Zhao, Ying Gao, Junqing Zhang, Liaqat Ali. [Retracted] Alteration of Intestinal Microbiota and Hydrogen Sulfide Metabolism in Patients with Hashimoto’s Thyroiditis. Journal of Healthcare Engineering 2023; 2023(1) doi: 10.1155/2023/9302189
44
Morris Gordon, Ciaran Grafton-Clarke, Vassiliki Sinopoulou, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013743
45
Xiao-Bo Feng, Jun Jiang, Min Li, Gang Wang, Jin-Wei You, Jian Zuo. Role of intestinal flora imbalance in pathogenesis of pouchitis. Asian Pacific Journal of Tropical Medicine 2016; 9(8) doi: 10.1016/j.apjtm.2016.06.003
46
Shouzhi Zhou, Zhao Yang, Jiaxin Liu, Maojuan Ran. TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation. Immunology Letters 2023; 255 doi: 10.1016/j.imlet.2023.02.005
47
Hee Seo, Hyunbin Seong, Ga Yun Kim, Yu Mi Jo, Seong Won Cheon, Youngju Song, Byung Hee Ryu, Hee Kang, Nam Soo Han. Development of Anti-inflammatory Probiotic Limosilactobacillus reuteri EFEL6901 as Kimchi Starter: in vitro and In vivo Evidence. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.760476
48
Catalina Grez, Juan Cristóbal Ossa. ENFERMEDAD INFLAMATORIA INTESTINAL EN PEDIATRÍA, UNA REVISIÓN. Revista Médica Clínica Las Condes 2019; 30(5) doi: 10.1016/j.rmclc.2019.06.009
49
Andrew Del Colle, Narek Israelyan, Kara Gross Margolis. Novel aspects of enteric serotonergic signaling in health and brain-gut disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1) doi: 10.1152/ajpgi.00173.2019
50
Jeannette S. Messer, Eugene B. Chang. Physiology of the Gastrointestinal Tract. 2018;  doi: 10.1016/B978-0-12-809954-4.00036-0
51
Kaitlyn E. Barrack, George A. O'Toole, Melissa M. Kendall. Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiota. Journal of Bacteriology 2025; 207(9) doi: 10.1128/jb.00167-25
52
Radhika Gudi, Jada Suber, Robert Brown, Benjamin M Johnson, Chenthamarakshan Vasu. Pretreatment with Yeast-Derived Complex Dietary Polysaccharides Suppresses Gut Inflammation, Alters the Microbiota Composition, and Increases Immune Regulatory Short-Chain Fatty Acid Production in C57BL/6 Mice. The Journal of Nutrition 2020; 150(5) doi: 10.1093/jn/nxz328
53
Sarah El-Nakeep. Frontiers of COVID-19. 2022;  doi: 10.1007/978-3-031-08045-6_14
54
Fabrício Freire de Melo, Maria Luísa Cordeiro Santos, Filipe Antônio França da Silva, Breno Bittencourt de Brito, Natália Oliveira e Silva. Probiotics in inflammatory bowel disease: Does it work?. World Journal of Meta-Analysis 2020; 8(2): 54-66 doi: 10.13105/wjma.v8.i2.54
55
Ioanna Aggeletopoulou, Christos Konstantakis, Stelios F. Assimakopoulos, Christos Triantos. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microbial Pathogenesis 2019; 137 doi: 10.1016/j.micpath.2019.103774
56
Lama Izzat Hasan Abdel-Rahman, Xochitl C Morgan. Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis. Inflammatory Bowel Diseases 2023; 29(1) doi: 10.1093/ibd/izac194
57
Francesco Strati, Georgia Lattanzi, Chiara Amoroso, Federica Facciotti. Microbiota-targeted therapies in inflammation resolution. Seminars in Immunology 2022; 59 doi: 10.1016/j.smim.2022.101599
58
Adeline Sivignon, Julie Bouckaert, Julien Bernard, Sebastien G. Gouin, Nicolas Barnich. The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. Expert Opinion on Therapeutic Targets 2017; 21(9) doi: 10.1080/14728222.2017.1363184
59
Carolina Palmela, Caroline Chevarin, Zhilu Xu, Joana Torres, Gwladys Sevrin, Robert Hirten, Nicolas Barnich, Siew C Ng, Jean-Frederic Colombel. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 2018; 67(3) doi: 10.1136/gutjnl-2017-314903
60
Sulejman Alihodžić, Mirjana Bukvić, Ivaylo J. Elenkov, Antun Hutinec, Sanja Koštrun, Dijana Pešić, Gordon Saxty, Linda Tomašković, Dinko Žiher. . Progress in Medicinal Chemistry 2018; 57 doi: 10.1016/bs.pmch.2018.01.002
61
Yufei Zhang, Gaogao Xue, Fan Wang, Jing Zhang, Lida Xu, Changyuan Yu. The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1382332
62
Sreedhar Subramanian, Anders Ekbom, Jonathan M Rhodes. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?. Gut 2017; 66(2) doi: 10.1136/gutjnl-2016-312673
63
Wei Niu, Fuyan Yang, Ziwei Fu, Yuelin Dong, Zhenhai Zhang, Jianming Ju. The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease. Microbial Pathogenesis 2022; 165 doi: 10.1016/j.micpath.2021.105381
64
Tiziana LARUSSA, Ludovico ABENAVOLI, Giulia FABIANO, Maria A. MANCUSO, Natale POLIMENI, Dan L. DUMITRASCU, Francesco LUZZA. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02907-7
65
Federica Facciotti. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases. PharmaNutrition 2022; 21 doi: 10.1016/j.phanu.2022.100303
66
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials 2021; 11(8) doi: 10.3390/nano11082035
67
Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020; 9(5) doi: 10.3390/cells9051234
68
Áine Abautret-Daly, Elaine Dempsey, Adolfo Parra-Blanco, Carlos Medina, Andrew Harkin. Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatrica 2018; 30(5) doi: 10.1017/neu.2017.3
69
Glenn T. Ault, Jennifer S. Beaty. The ASCRS Textbook of Colon and Rectal Surgery. 2022;  doi: 10.1007/978-3-030-66049-9_2
70
Wael Elhenawy, Sarah Hordienko, Steven Gould, Alexander M. Oberc, Caressa N. Tsai, Troy P. Hubbard, Matthew K. Waldor, Brian K. Coombes. High-throughput fitness screening and transcriptomics identify a role for a type IV secretion system in the pathogenesis of Crohn’s disease-associated Escherichia coli. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22306-w
71
MARIA ALMEIDA, ANGGA CIPTA NARSA, SRI AGUNG FITRI KUSUMA, SRIWIDODO SRIWIDODO. OPTIMIZATION OF LACTOBACILLUS PLANTARUM FERMENTATION FOR ENHANCED PHENOLIC PRODUCTION FROM EXTRACT OF BAJAKAH BARK (UNCARIA NERVOSA) BY RESPONSE SURFACE METHODOLOGY. International Journal of Applied Pharmaceutics 2023;  doi: 10.22159/ijap.2023.v15s2.23
72
Taylor L. Spiewak, Ted A. Spiewak, Anish Patel. Ixekizumab-associated severe Crohn’s in a patient without definitive immune-mediated inflammatory disease: case report and evidence-informed guidance for non-IBD clinicians. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.1005103
73
Katlyn M. Smaha, Silas M. Money, Loretta S. Davis. Review of dermatologic drugs relevant to inflammatory bowel disease. JAAD Reviews 2024; 1 doi: 10.1016/j.jdrv.2024.07.001
74
Alexander Rodriguez-Palacios, Abigail Raffner Basson, Fabio Cominelli. Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?. Gastroenterology 2021; 161(1) doi: 10.1053/j.gastro.2021.03.041
75
Damjana Bogatic, Robert V. Bryant, Kate D. Lynch, Samuel P. Costello. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2023; 57(1) doi: 10.1111/apt.17251
76
Stephanie N. Spohn, Vincent B. Young. Physiology of the Gastrointestinal Tract. 2018;  doi: 10.1016/B978-0-12-809954-4.00032-3
77
Yu-Chen Lee, Chih-Yi Liu, Chia-Long Lee, Ruo-Han Zhang, Chi-Jung Huang, Ting-Lin Yen. The Periodontopathic Pathogen, Porphyromonas gingivalis, Involves a Gut Inflammatory Response and Exacerbates Inflammatory Bowel Disease. Pathogens 2022; 11(1) doi: 10.3390/pathogens11010084
78
Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong, Dapeng Chen. Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacology & Therapeutics 2021; 226 doi: 10.1016/j.pharmthera.2021.107859
79
Karin Fetter, Markus Weigel, Benjamin Ott, Moritz Fritzenwanker, Sebastian Stricker, Jan de Laffolie, Torsten Hain. The microbiome landscape in pediatric Crohn’s disease and therapeutic implications. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2247019
80
Gordon W Moran, Morris Gordon, Vassiliki Sinopoulou, Shellie J Radford, Ana-Maria Darie, Sudheer Kumar Vuyyuru, Laith Alrubaiy, Naila Arebi, Jonathan Blackwell, Thomas D Butler, Thean Chew, Michael Colwill, Rachel Cooney, Gabriele De Marco, Said Din, Shahida Din, Roger Feakins, Marco Gasparetto, Hannah Gordon, Richard Hansen, Klaartje B Kok, Aditi Kumar, Christopher A Lamb, Jimmy Limdi, Eleanor Liu, Maurice B Loughrey, Dennis McGonagle, Kamal Patel, Polychronis Pavlidis, Christian Selinger, Matthew Shale, Philip J Smith, Sreedhar Subramanian, Stuart A Taylor, Gloria Shwe Zin Tun, Ajay Mark Verma, Newton A C S Wong. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut 2025; 74(Suppl 2) doi: 10.1136/gutjnl-2024-334395
81
Ha T Doan, Li-Chieh Cheng, Yi-Ling Chiu, Yuan-Kai Cheng, Cheng-Chih Hsu, Yee-Chun Chen, Hsiu-Jung Lo, Hao-Sen Chiang. Candida tropicalis -derived vitamin B3 exerts protective effects against intestinal inflammation by promoting IL-17A/IL-22-dependent epithelial barrier function . Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2416922
82
Saqr Alsakarneh, Michael Camilleri, Francis A. Farraye, Jana G. Hashash. Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States. Digestive Diseases and Sciences 2025; 70(8) doi: 10.1007/s10620-025-09039-2
83
Xuanyu Wei, Dong Tang. Effect of Bacteroides on Crohn’s disease. Zeitschrift für Gastroenterologie 2025; 63(04) doi: 10.1055/a-2435-2659
84
Kseniya M. Achasova, Elena N. Kozhevnikova, Mariya A. Borisova, Ekaterina A. Litvinova. Fucose Ameliorates Tritrichomonas sp.-Associated Illness in Antibiotic-Treated Muc2−/− Mice. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910699
85
Mahboube Ganji‐Arjenaki, Mahmoud Rafieian‐Kopaei. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. Journal of Cellular Physiology 2018; 233(3) doi: 10.1002/jcp.25911
86
Merve Yürük, Emrah Erdoğan, Eda Sivcan. Intestinal protozoa in celiac disease: Detection and phylogenetic characterization. Tropical Parasitology 2026; 16(1) doi: 10.4103/tp.tp_61_25
87
Mabel Guzman-Rodriguez, Julie A.K. McDonald, Richard Hyde, Emma Allen-Vercoe, Erika C. Claud, Prameet M. Sheth, Elaine O. Petrof. Using bioreactors to study the effects of drugs on the human microbiota. Methods 2018; 149 doi: 10.1016/j.ymeth.2018.08.003
88
Robel Tadesse, Biniam Ewnte, Kale’ab Tesfaye. Perforated ileum as the initial presentation of Crohn's disease, a case report. International Journal of Surgery Case Reports 2022; 97(C) doi: 10.1016/j.ijscr.2022.107305
89
Ahmad Qasem, Abed Elrahman Naser, Saleh A. Naser. The alternate effects of anti-TNFα therapeutics and their role in mycobacterial granulomatous infection in Crohn’s disease. Expert Review of Anti-infective Therapy 2017; 15(7) doi: 10.1080/14787210.2017.1328276
90
Mohammad Al Mijan, Beong Ou Lim. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World Journal of Gastroenterology 2018; 24(25): 2673-2685 doi: 10.3748/wjg.v24.i25.2673
91
Boshen Gong, Chuyuan Wang, Fanrui Meng, Haoyu Wang, Bo Song, Yang Yang, Zhongyan Shan. Association Between Gut Microbiota and Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.774362
92
Ayla Demirtas. The lived experiences of people with inflammatory bowel diseases: A phenomenological hermeneutic study. International Journal of Nursing Practice 2022; 28(3) doi: 10.1111/ijn.12946
93
Shraddha Jatwani, Bharat Malhotra, Teresa Crout, Vikas Majithia. Infections and the Rheumatic Diseases. 2019;  doi: 10.1007/978-3-030-23311-2_37
94
JRS Dandrieux, LM Martinez Lopez, N Prakash, CS Mansfield. Treatment response and long term follow up in nineteen dogs diagnosed with chronic enteropathy in Australia. Australian Veterinary Journal 2019; 97(9) doi: 10.1111/avj.12846
95
Bárbara M. Schultz, Carolina A. Paduro, Geraldyne A. Salazar, Francisco J. Salazar-Echegarai, Valentina P. Sebastián, Claudia A. Riedel, Alexis M. Kalergis, Manuel Alvarez-Lobos, Susan M. Bueno. A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00191
96
Olusoji Oyesola, Oluwaseye Olayemi, Olaniyi Soetan, Eunice Ojo-Adebayo. Comparative effects of ciprofloxacin and prednisolone on renal function markers in a TNBS-induced Crohn's disease rat model. Kragujevac Journal of Science 2025; 47(2) doi: 10.5937/KgJSci2502051O
97
J. R. S. Dandrieux. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same?. Journal of Small Animal Practice 2016; 57(11) doi: 10.1111/jsap.12588
98
Toumi Ryma, Arezki Samer, Imene Soufli, Hayet Rafa, Chafia Touil-Boukoffa. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterology Insights 2021; 12(1) doi: 10.3390/gastroent12010006
99
Siyu Li, Kan Xu, Yi Cheng, Lu Chen, Ailin Yi, Zhifeng Xiao, Xuefei Zhao, Minjia Chen, Yuting Tian, Wei Meng, Zongyuan Tang, Shuhong Zhou, Guangcong Ruan, Yanling Wei. The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1188455
100
Yin Zhang, Xue Li, Qiwen Fang, Deliang Yang, Krishnan Bhaskaran, Angel Y.S. Wong, Wai K. Leung. Association Between Antibiotic Use for Nongastrointestinal Infections and Inflammatory Bowel Disease Flare-Ups: A Self-Controlled Case Series Study. American Journal of Gastroenterology 2026;  doi: 10.14309/ajg.0000000000003920
101
Tom Walraven, Mathias Busch, Jingxuan Wang, Joanne M. Donkers, Marjolijn Duijvestein, Evita van de Steeg, Nynke I. Kramer, Hans Bouwmeester. Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review. Archives of Toxicology 2024; 98(11) doi: 10.1007/s00204-024-03844-w
102
Xuewei Ye, Anqi Wang, Wenting Lin, Yiwen Xu, Xinyi Dong, Yue Zhou, Kewei Tian, Xiaoling Xu. The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy. Frontiers in Bioscience-Landmark 2022; 27(10) doi: 10.31083/j.fbl2710281
103
Phage Therapy - Part B. Progress in Molecular Biology and Translational Science 2023; 201 doi: 10.1016/bs.pmbts.2023.04.005
104
Shu-Ran Zhang, Guang-Juan Xu, Wei Xie, Na Xu, Yan-Hong Xu, Xiao-Li Hu, Zhong-Min Su. A water-stable Cd-MOF acts as new fluorescent probe for detecting Fe3+, Cr2O72−, 2,4,6-trinitrophenol and nitrofurazone. Journal of Solid State Chemistry 2024; 338 doi: 10.1016/j.jssc.2024.124900
105
Kofi Clarke, Dominic Amakye, Jiqing Shi, Shannon Dalessio, Kara DiJoseph, Matthew D. Coates. Empiric Antibiotic Use With Rescue Infliximab Does Not Improve Outcomes in Acute Severe Ulcerative Colitis: A Retrospective Cohort Study. Health Science Reports 2025; 8(8) doi: 10.1002/hsr2.71165
106
Dídia Bismara CURY, Liana Cristina Bismara CURY, Ana Camila MICHELLETTI, Rogerio Antonio OLIVEIRA, Elsa Alidia Petry GONÇALVES, Nestor SCHOR. RISK FACTORS FOR RENAL CALCULI IN PATIENTS WITH CROHN’S DISEASE. Arquivos de Gastroenterologia 2025; 62 doi: 10.1590/s0004-2803.24612024-023
107
Darren Fernandes, Jervoise Andreyev. The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy. Microorganisms 2022; 10(8) doi: 10.3390/microorganisms10081613
108
Sebastian Gallo-Bernal, Alexis M. Cahalane, Michael S. Gee. Percutaneous Image-Guided Drainage of Abdominal Fluid Collections in Children: Technical Considerations and Clinical Scenarios. Digestive Disease Interventions 2023; 7(03) doi: 10.1055/s-0042-1759547
109
Sabine Hazan, Neil Stollman, Huseyin S Bozkurt, Sonya Dave, Andreas J Papoutsis, Jordan Daniels, Brad D Barrows, Eamonn MM Quigley, Thomas J Borody. Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterology 2022; 9(1) doi: 10.1136/bmjgast-2022-000871
110
Wei Du, Weili Han, Jiaqiang Dong. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Medical Hypotheses 2020; 144 doi: 10.1016/j.mehy.2020.110211
111
Xiujing Zhang, Lizhuan Ma, Chao Zhang, Bingxu Hou, Yanli Zhou, Simiao Yu. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterología y Hepatología (English Edition) 2021; 44(9) doi: 10.1016/j.gastre.2021.09.004
112
Meng Wang, Kailin Liu, Wu Bao, Bingqing Hang, Xianjiong Chen, Xinyi Zhu, Guifang Li, Lihong Liu, Haoyi Xiang, Hai Hu, Yanhui Lu, Zhangfa Song, Jiaxin Chen, Yuhao Wang. Gut microbiota protect against colorectal tumorigenesis through lncRNA Snhg9. Developmental Cell 2025; 60(7) doi: 10.1016/j.devcel.2024.12.013
113
Yeyong Wang, Cheng Gao, Zhi Qu, Ming Li. The combined toxicity of binary mixtures of antibiotics against the cyanobacterium Microcystis is dose-dependent: insight from a theoretical nonlinear combined toxicity assessment method. Environmental Science and Pollution Research 2022; 29(8) doi: 10.1007/s11356-021-16594-4
114
Peijie Zhong, Hang Wu, Yuanqiao Ma, Xiaoxiao Xu, Yizhuo Jiang, Chaolei Jin, Qiaozhen Zhu, Xinlei Liu, Zhimin Suo, Junpeng Wang. P2X4 receptor modulates gut inflammation and favours microbial homeostasis in colitis. Clinical and Translational Medicine 2023; 13(4) doi: 10.1002/ctm2.1227
115
J. Plaza-Diaz, F.J. Ruiz-Ojeda, M.J. Arias-Tellez, P. Solis-Urra, M.J. Saez-Lara, A. Gil. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019;  doi: 10.1016/B978-0-12-815249-2.00015-4
116
Zhenhuan Yang, Wenjing Liu, Xuefeng Zhou, Xiaoran Zhu, Feiya Suo, Shukun Yao. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease. Medicine 2020; 99(43) doi: 10.1097/MD.0000000000022916
117
Peter Girgis, Tanisha LNU, Amna Ahmad, Mina Daniel, Maria Kamel, Jade L Gambill, Atika Shahzadi, Usman Khan, Anam Zara, Vagisha Sharma. Advancements in Targeted Therapies for the Management of Crohn’s Disease: A Comprehensive Review. Cureus 2024;  doi: 10.7759/cureus.61751
118
Gülbeyaz Özkan, Derya Demir, İrem Taner, Nur Banu Bal, Mürşide Demirel. Deneysel Sıçan Kolit Modelinde Alfa Lipoik Asit Tedavisinin SOD ve NLRP3 Seviyesi Üzerine Etkisi. Laboratuvar Hayvanları Bilimi ve Uygulamaları Dergisi 2025; 5(1) doi: 10.62425/jlasp.1565052
119
Guoqing Zhao, Hongxia Li, Liwei Huang, Yu Cheng, Jia Liu, Ruigao Song, Xi Wang. Integrated multi-omics analysis reveals that Gongying San ameliorates subclinical mastitis by modulating intestinal microbiota and metabolites in dairy cows. Frontiers in Veterinary Science 2025; 12 doi: 10.3389/fvets.2025.1589900
120
Scott D. Lee, Anand Singla, Stephen J. Rulyak, Kindra Clark‐Snustad. Double‐blind, randomised, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease. GastroHep 2020; 2(5) doi: 10.1002/ygh2.416
121
Daniel A. Schupack, Ruben A. T. Mars, Dayne H. Voelker, Jithma P. Abeykoon, Purna C. Kashyap. The promise of the gut microbiome as part of individualized treatment strategies. Nature Reviews Gastroenterology & Hepatology 2022; 19(1) doi: 10.1038/s41575-021-00499-1
122
Atsushi Kohyama, Kazuhiro Watanabe, Akira Sugita, Kitaro Futami, Hiroki Ikeuchi, Ken-ichi Takahashi, Yasuo Suzuki, Kouhei Fukushima. Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy. Journal of Gastroenterology 2021; 56(3) doi: 10.1007/s00535-020-01742-3
123
Shivani Yadav, Dhruvi Shah, Parmeswar Dalai, Reena Agrawal-Rajput. The tale of antibiotics beyond antimicrobials: Expanding horizons. Cytokine 2023; 169 doi: 10.1016/j.cyto.2023.156285
124
Omari Jones-Nelson, Andrey Tovchigrechko, Matthew S. Glover, Fiona Fernandes, Udaya Rangaswamy, Hui Liu, David E. Tabor, Jonathan Boyd, Paul Warrener, Jose Martinez, Jamese J. Hilliard, C. Ken Stover, Wen Yu, Gina DAngelo, Sonja Hess, Taylor S. Cohen, Bret R. Sellman. Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function. Antimicrobial Agents and Chemotherapy 2020; 64(5) doi: 10.1128/AAC.02347-19
125
Cintia R. R. Queiroz-Machado, Mohsen Hanifeh, Enrico Bottero, Chi-Hsuan Sung, Patricia Eri Ishii, Roberto M. C. Guedes, Raphael R. Wenceslau, Susanne Kilpinen, Thomas Spillmann, Jonathan A. Lidbury, Joerg M. Steiner, Jan S. Suchodolski, Paula R. Giaretta, Tofazzal Md Rakib. Abundance of bacteria and histopathologic findings in the small intestinal mucosa of dogs with chronic inflammatory enteropathies. PLOS One 2025; 20(12) doi: 10.1371/journal.pone.0337930
126
Cambrian Y. Liu, D. Brent Polk. Microbiomes through the Looking Glass: What Do UC?. Cell Host & Microbe 2018; 24(4) doi: 10.1016/j.chom.2018.09.013
127
Abdullah Hoter, Hassan Y. Naim. The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease—An Update. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215331
128
Bo-Zong Shao, Shu-Ling Wang, Jun Fang, Zhao-Shen Li, Yu Bai, Kai Wu. Alpha7 Nicotinic Acetylcholine Receptor Alleviates Inflammatory Bowel Disease Through Induction of AMPK-mTOR-p70S6K-Mediated Autophagy. Inflammation 2019; 42(5) doi: 10.1007/s10753-019-01027-9
129
Helioswilton Sales-Campos, Siomar Castro Soares, Carlo José Freire Oliveira. An introduction of the role of probiotics in human infections and autoimmune diseases. Critical Reviews in Microbiology 2019; 45(4) doi: 10.1080/1040841X.2019.1621261
130
Mengfan Li, Lijiao Yang, Chenlu Mu, Yue Sun, Yu Gu, Danfeng Chen, Tianyu Liu, Hailong Cao. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Computational and Structural Biotechnology Journal 2022; 20 doi: 10.1016/j.csbj.2022.03.038
131
Annika Fernandez Milano, Sarah Krieg, Karel Kostev. Medication Burden Before and After Prescription of Biologics in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2024; 13(21) doi: 10.3390/jcm13216408
132
Belgin Dogan, Jing Fu, Shiying Zhang, Ellen J. Scherl, Kenneth W. Simpson. Rifaximin decreases virulence of Crohn’s disease-associated Escherichia coli and epithelial inflammatory responses. The Journal of Antibiotics 2018; 71(5) doi: 10.1038/s41429-017-0022-y
133
Sonia Fernández-Veledo, Carme Grau-Bové, Sara Notararigo, Isabel Huber-Ruano. The role of microbial succinate in the pathophysiology of inflammatory bowel disease: mechanisms and therapeutic potential. Current Opinion in Microbiology 2025; 85 doi: 10.1016/j.mib.2025.102599
134
Fotios S. Fousekis, Konstantinos Mpakogiannis, Ioanna Nefeli Mastorogianni, Georgios D. Lianos, Dimitrios K. Christodoulou, Konstantinos H. Katsanos. Intestinal Fibrosis in Crohn’s Disease: Pathophysiology, Diagnosis, and New Therapeutic Targets. Journal of Clinical Medicine 2025; 14(12) doi: 10.3390/jcm14124060
135
Shuai Wang, Rene Martins, Megan C. Sullivan, Elliot S. Friedman, Ana M. Misic, Ayah El-Fahmawi, Elaine Cristina Pereira De Martinis, Kevin O’Brien, Ying Chen, Charles Bradley, Grace Zhang, Alexander S. F. Berry, Christopher A. Hunter, Robert N. Baldassano, Mark P. Rondeau, Daniel P. Beiting. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome 2019; 7(1) doi: 10.1186/s40168-019-0740-4
136
Mélissa Chervy, Nicolas Barnich, Jérémy Denizot. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn’s Disease. International Journal of Molecular Sciences 2020; 21(10) doi: 10.3390/ijms21103734
137
Catherine Colquhoun, Michelle Duncan, George Grant. Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. Diseases 2020; 8(2) doi: 10.3390/diseases8020013
138
Hoon Kim, Eun-Jin Jeong, Byungdoo Hwang, Hak-Dong Lee, Sanghyun Lee, Mi Jang, Kwangeun Yeo, Yunjeong Shin, Sanghoon Park, Wan Taek Lim, Woo Jung Kim, Sung-Kwon Moon. Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice. Phytomedicine 2024; 124 doi: 10.1016/j.phymed.2023.155301
139
Hyemee Kim, Kimberly A. Krenek, Chuo Fang, Yasushi Minamoto, Melissa E. Markel, Jan S. Suchodolski, Stephen T. Talcott, Susanne U. Mertens-Talcott. Polyphenolic derivatives from mango (Mangifera Indica L.) modulate fecal microbiome, short-chain fatty acids production and the HDAC1/AMPK/LC3 axis in rats with DSS-induced colitis. Journal of Functional Foods 2018; 48 doi: 10.1016/j.jff.2018.07.011
140
Peng Zhang, Hua Jiang. Acetyl‐11‐keto‐β‐boswellic Acid Confers Protection in DSS‐Induced Colitis via the JNK–p38 MAPK and NF‐κB Signaling Pathways. Advanced Biology 2023; 7(6) doi: 10.1002/adbi.202200247
141
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1563805
142
Ana Paula da Fonseca Machado, Marina Vilar Geraldi, Roberto de Paula do Nascimento, Amanda Maria Tomazini Munhoz Moya, Teresa Vezza, Patricia Diez-Echave, Julio Juan Gálvez, Cinthia Bau Betim Cazarin, Mário Roberto Maróstica Júnior. Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Research International 2021; 140 doi: 10.1016/j.foodres.2020.110018
143
Morris Gordon, Vassiliki Sinopoulou, Ciaran Grafton-Clarke, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD013743.pub2
144
Danilo Pagliari, Giovanni Gambassi, Ciriaco A. Piccirillo, Rossella Cianci. The Intricate Link among Gut “Immunological Niche,” Microbiota, and Xenobiotics in Intestinal Pathology. Mediators of Inflammation 2017; 2017 doi: 10.1155/2017/8390595
145
Elio Rossi, Gabriella Leccese, Valerio Baldelli, Alessia Bibi, Emanuele Scalone, Carlo Camilloni, Moira Paroni, Paolo Landini. Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn’s Disease-Associated Adherent Invasive Escherichia coli LF82 Strain. Microorganisms 2022; 10(3) doi: 10.3390/microorganisms10030537
146
Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui-Lung Sun, Marc Bissonnette, Haochu Huang, Chuan He. A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T Cells. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(4) doi: 10.1016/j.jcmgh.2020.07.001
147
Simon Kusan, Güzin Surat, Matthias Kelm, Friedrich Anger, Mia Kim, Christoph-Thomas Germer, Nicolas Schlegel, Sven Flemming. Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease. Journal of Clinical Medicine 2022; 11(15) doi: 10.3390/jcm11154343
148
Banafsheh Nadalian, Bahareh Nadalian, Hamidreza Houri, Shabnam Shahrokh, Mohammad Abdehagh, Abbas Yadegar, Gholamhossein Ebrahimipour. Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.985300
149
Emanuele Sinagra, Erika Utzeri, Gaetano Cristian Morreale, Carlo Fabbri, Fabio Pace, Andrea Anderloni. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
150
Mahdi Mohaqiq, Roger Palou, Ruizhen Li, Guijun Zhang, Het Vaishnav, Florance Parweez, Terence Moyana, Damian Carragher, D. W. Cameron, Timothy Ramsay, Almer M. van der Sloot, Sanjay Murthy, Brian K. Coombes, Mike Tyers, X. Johné Liu. Engineered spermidine-secreting Saccharomyces boulardii ameliorates colitis and colon cancer in mice. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-16736-5
151
Gabriela Seydlová, Radek Pohl, Eva Zborníková, Marcel Ehn, Ondřej Šimák, Natalya Panova, Milan Kolář, Kateřina Bogdanová, Renata Večeřová, Radovan Fišer, Hana Šanderová, Dragana Vítovská, Petra Sudzinová, Jiří Pospíšil, Oldřich Benada, Tomáš Křížek, David Sedlák, Petr Bartůněk, Libor Krásný, Dominik Rejman. Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents. Journal of Medicinal Chemistry 2017; 60(14) doi: 10.1021/acs.jmedchem.7b00355
152
Annalisa Di Rienzo, Lisa Marinelli, Marilisa Pia Dimmito, Eleonora Chiara Toto, Antonio Di Stefano, Ivana Cacciatore. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091185
153
Andreas Munk Petersen. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases. APMIS 2022; 130(S144) doi: 10.1111/apm.13256
154
Jongwook Yu, Jae Hee Cheon. Microbial Modulation in Inflammatory Bowel Diseases. Immune Network 2022; 22(6) doi: 10.4110/in.2022.22.e44
155
Ting Zhang, Hongyu Zhong, Min Yang, Xin Shi, Liuqing Yang, Jie Yang, Haifeng Liu, Yan Luo, Yue Xie, Zhijun Zhong, Guangneng Peng, Kun Zhang, Chengli Zheng, Ming Zhang, Ziyao Zhou. Lactobacillus salivary LSbg3 is a Potential Food Probiotic Having Excellent Anti-pathogen Effect That Might Improve Antibiotic-Resistant Diarrhea in Dogs. Probiotics and Antimicrobial Proteins 2026; 18(1) doi: 10.1007/s12602-025-10527-0
156
Hicheme Hadji, Kawthar Bouchemal. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Advanced Drug Delivery Reviews 2022; 181 doi: 10.1016/j.addr.2021.114101
157
Manisha S. Lalan, Pranav J. Shah, Ruchita Kadam, Himan P. Patel. Amalgam of Ternary Solid Dispersion and P-gp Efflux Inhibition in Development of Colon-targeted Tablets of Rifaximin. Journal of Reports in Pharmaceutical Sciences 2022; 11(2) doi: 10.4103/jrptps.JRPTPS_21_22
158
Weijie Ma, Zimu Gong, Hamzah Abu-Sbeih, Yuanzun Peng, Frederick Peng, Fangwen Zou, Aline Charabaty, Pablo C. Okhuysen, Jennifer L. McQuade, Mehmet Altan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang. Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections. American Journal of Clinical Oncology 2021; 44(8) doi: 10.1097/COC.0000000000000841
159
Albert E. Jergens, Shadi Parvinroo, Jamie Kopper, Michael J. Wannemuehler. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.669913
160
Anum Khan, Amna Bibi, Huma Ali, Asim ur Rehman, Maimoona Qindeel, Muhammad Irfan, Aamer Ali Shah, Malik Badshah, Fariha Hasan, Samiullah Khan. Development of Resistant Starch Film Coated Microparticles for an Oral Colon‐Specific Drug Delivery. Starch - Stärke 2020; 72(7-8) doi: 10.1002/star.201900262
161
Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel, Supriya Roy, Pratishtha Sharma, Varunesh Chaturvedi, Saloni Goyal, Mohsina F. Patewkar. CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT. Indian Drugs 2022; 59(09) doi: 10.53879/id.59.09.12577
162
Huimin Jin, Siyan Che, Kunfu Wu, Miaomiao Wu. Ellagic acid prevents gut damage via ameliorating microbe-associated intestinal lymphocyte imbalance. Food & Function 2022; 13(19) doi: 10.1039/D2FO01512A
163
Kaori Yoshida, Masanori A. Murayama, Kenji Shimizu, Ce Tang, Nanako Katagiri, Kenzo Matsuo, Fumio Fukai, Yoichiro Iwakura. IL-1R2 deficiency suppresses dextran sodium sulfate-induced colitis in mice via regulation of microbiota. Biochemical and Biophysical Research Communications 2018; 496(3) doi: 10.1016/j.bbrc.2018.01.116
164
Vikash G. Lala, Bilal Bobat, Mark Haagensen, Prakash Kathan, Adam Mahomed. Metronidazole-induced encephalopathy. South African Journal of Radiology 2021; 25(1) doi: 10.4102/sajr.v25i1.2016
165
Justin A. Hutcherson, Kathryn M. Sinclair, Benjamin R. Belvin, Qin Gui, Paul S. Hoffman, Janina P. Lewis. Amixicile, a novel strategy for targeting oral anaerobic pathogens. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09616-0
166
Kathryn Timko. Approach to Inflammatory Bowel Disease. Veterinary Clinics of North America: Equine Practice 2024; 40(2) doi: 10.1016/j.cveq.2024.04.004
167
Iva Veseli, Yiqun T Chen, Matthew S Schechter, Chiara Vanni, Emily C Fogarty, Andrea R Watson, Bana Jabri, Ran Blekhman, Amy D Willis, Michael K Yu, Antonio Fernàndez-Guerra, Jessika Füssel, A Murat Eren. Microbes with higher metabolic independence are enriched in human gut microbiomes under stress. eLife 2025; 12 doi: 10.7554/eLife.89862.3
168
Richard Kellermayer. The treatment naïve microbiome of pediatric ulcerative colitis and microbial therapeutics: A humbling challenge. Saudi Journal of Gastroenterology 2025; 31(1) doi: 10.4103/sjg.sjg_360_24
169
Matthew D Coates, Kofi Clarke, Emmanuelle Williams, Nimalan Jeganathan, Sanjay Yadav, David Giampetro, Vitaly Gordin, Sadie Smith, Kent Vrana, Anne Bobb, Thu Thi Gazzio, Heather Tressler, Shannon Dalessio. Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review. Crohn's & Colitis 360 2023; 5(4) doi: 10.1093/crocol/otad055
170
Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Anquan Shang, Francis Atim Akanyibah, Fei Mao. The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomedicine & Pharmacotherapy 2024; 179 doi: 10.1016/j.biopha.2024.117302
171
Hyun Young Shin, Seon Gyeong Yu, Jong-Eun Kim, Kwang-Soon Shin, Hyung Joo Suh, Kwang-Won Yu. Rhamnogalacturonan-I-rich polysaccharide from Malus prunifolia attenuates dextran sulfate sodium-induced colitis and improves the gut microenvironment. International Journal of Biological Macromolecules 2026; 348 doi: 10.1016/j.ijbiomac.2026.150741
172
Stanisław Niemczyk, Wojciech Niemczyk, Katarzyna Bąk-Drabik, Katarzyna Latusek-Kotyczka, Anna Zawilska, Rafał Wiench, Jakub Hadzik, Marzena Dominiak. Patient with Inflammatory Bowel Disease in a Dental Office—Which Antibiotic to Choose?—Narrative Review. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238392
173
Yuyuan Hu, Yan Li, Qiang Zhang, Qiaobo Tan, Haoze Liu, Yuhang Yang, Chenfei Jin, Wei Zhang, Jinghan Jia, Jinxi Wang. The AMP–antibiotic–microbiota triad in IBD: a mechanistic framework for dysregulated antimicrobial defense. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1779550
174
Yu Zhou, Fang Shen. Advancements in therapeutic strategies and drug development for inflammatory bowel diseases. Exploration of Immunology 2025; 5 doi: 10.37349/ei.2025.1003232
175
Loren Galler Rabinowitz, Stephanie Lauren Gold, Elana A. Maser. Management of Inpatient Inflammatory Bowel Disease. 2022;  doi: 10.1007/978-1-0716-1987-2_3
176
Ying-Kai Hung, Shang-Tse Ho, Ching-Yun Kuo, Ming-Ju Chen. Multiomics Strategy Reveals the Mechanism of Action and Ameliorating Effect of Deer Velvet Antler Water Extracts on DSS-Induced Colitis. Biomedicines 2023; 11(7) doi: 10.3390/biomedicines11071913
177
Samira Alipour, Mina Owrang, Mohsen Rajabnia, Meysam Olfatifar, Hossein Kazemian, Hamidreza Houri. Prevalence of Plasmid‐Mediated Quinolone Resistance Genes in Escherichia coli Isolates From Colonic Biopsies of Iranian Patients With Inflammatory Bowel Diseases: A Cross‐Sectional Study. Health Science Reports 2024; 7(12) doi: 10.1002/hsr2.70204
178
Kelly A. Hu, John Gubatan. Gut microbiome–based therapeutics in inflammatory bowel disease. Clinical and Translational Discovery 2023; 3(2) doi: 10.1002/ctd2.182
179
Wayne Young, Traci Jester, Matthew L. Stoll, Ana Izcue. The Microbiome in Rheumatic Diseases and Infection. 2018;  doi: 10.1007/978-3-319-79026-8_19
180
İrem Taner, Nur Banu Bal, Saadet Özen Akarca Dizakar, Veysel Bay, Mürşide Ayşe Demirel. Therapeutic potential of alpha-lipoic acid on mitochondrial dynamics, oxidative/nitrosative stress, and histopathological changes in rat ulcerative colitis model. Inflammopharmacology 2025; 33(9) doi: 10.1007/s10787-025-01918-4
181
Yoshiyuki Mishima, Ryan Balfour Sartor. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. Journal of Gastroenterology 2020; 55(1) doi: 10.1007/s00535-019-01618-1
182
Ming Zhang, Kaiji Sun, Yujun Wu, Ying Yang, Patrick Tso, Zhenlong Wu. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00942
183
John Kuckelman, Eric K. Johnson. Clinical Algorithms in General Surgery. 2019;  doi: 10.1007/978-3-319-98497-1_70
184
Sota Katsube, Satohiro Matsumoto, Masahiro Misawa, Nao Kakizawa, Ryo Hashimoto, Taku Mizutani, Keita Matsumoto, Shuhei Yoshikawa, Hirosato Mashima. Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula. Biologics: Targets and Therapy 2024;  doi: 10.2147/BTT.S457300
185
Filip Ambrozkiewicz, Jakub Karczmarski, Maria Kulecka, Agnieszka Paziewska, Magdalena Niemira, Natalia Zeber-Lubecka, Edyta Zagorowicz, Adam Kretowski, Jerzy Ostrowski. In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn’s disease - a preliminary study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01444-3
186
Oumaira Rahmouni, Laurent Dubuquoy, Pierre Desreumaux, Christel Neut. Microbiote intestinal et développement des maladies inflammatoires chroniques de l’intestin. médecine/sciences 2016; 32(11) doi: 10.1051/medsci/20163211012
187
Klára Szentmihályi, Krisztina Süle, Anna Egresi, Anna Blázovics, Zoltán May. Metronidazole does not show direct antioxidant activity in in vitro global systems. Heliyon 2021; 7(4) doi: 10.1016/j.heliyon.2021.e06902
188
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, Sanaz Varshochi, Amirali Karimi, Hengameh Mojdeganlou, Paniz Mojdeganlou, Armin Razi, Farzaneh Ghanadinezhad, Alireza Shojaei, Ava Amiri, Mohsen Dashti, Afsaneh Ghasemzadeh, Omid Dadras, Esmaeil Mehraeen, Amir Masoud Afsahi. Retracted: Gut microbiota and COVID‐19: A systematic review. Health Science Reports 2023; 6(2) doi: 10.1002/hsr2.1080
189
Ritwik Patra, Saubhik Mitra, Nabarun Chandra Das, Suprabhat Mukherjee. Prebiotics, Probiotics and Nutraceuticals. 2022;  doi: 10.1007/978-981-16-8990-1_8
190
Weiwei Wang, Zhui Li, Qiqi Han, Yuming Guo, Bo Zhang, Romain D’inca. Dietary live yeast and mannan-oligosaccharide supplementation attenuate intestinal inflammation and barrier dysfunction induced by Escherichia coli in broilers. British Journal of Nutrition 2016; 116(11) doi: 10.1017/S0007114516004116
191
Alessia Finotti, Jessica Gasparello, Ilaria Lampronti, Lucia Carmela Cosenza, Giovanni Maconi, Vincenzo Matarese, Valentina Gentili, Dario Di Luca, Roberto Gambari, Michele Caselli. PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis. BMJ Open Gastroenterology 2017; 4(1) doi: 10.1136/bmjgast-2017-000172
192
Sucheta Mandal, Narayan Chandra Mandal. Recent Advances and Future Perspectives of Microbial Metabolites. 2023;  doi: 10.1016/B978-0-323-90113-0.00005-5
193
Tolulope Joshua Ashaolu, Samuel Fernández-Tomé. Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics. Trends in Food Science & Technology 2021; 112 doi: 10.1016/j.tifs.2021.04.040
194
Renxi Li, Susan Kartiko. Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis. The American Surgeon™ 2025; 91(6) doi: 10.1177/00031348251323704
195
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine. 2019;  doi: 10.1007/978-3-319-72303-7_9
196
Ting Cheng, Chen Xu, Jing Shao. Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases. Clinical and Experimental Medicine 2022; 23(4) doi: 10.1007/s10238-022-00935-9
197
Anara Babayeva, Bekir Çöl. CYTOTOXIC ACTIVITY OF EPETRABOROLE AGAINST CANCER CELL LINES. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2026; 12(2) doi: 10.30934/kusbed.1864288
198
Saeideh Momtaz, Mohammad Amir Azimian, Pardis Gharazi, Mustafa Dehnamaki, Zahra Rezaei, Mahban Rahimifard, Maryam Baeeri, Ali Reza Abdollahi, Mohammad Abdollahi, Mohammad Hosein Farzaei, Amir Hossein Abdolghaffari. The Hydro-alcoholic Extract of Achillea wilhelmsii C. Koch Ameliorates Acetic Acid-induced Ulcerative Colitis through TLR-4. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 2023; 93(1) doi: 10.1007/s40011-022-01404-9
199
Ben Chen, Dingwei Li, Bingjie Tong, Lifen Wang, Haoran Lin, Helin Xu, Sunkuan Hu. Oral alginate microspheres for the efficient site-specific delivery of epidermal growth factor attenuated murine ulcerative colitis via repairing the mucosal barrier. International Journal of Pharmaceutics 2024; 661 doi: 10.1016/j.ijpharm.2024.124394
200
Elena K. Perry, Barath Udayasuryan, Elias K. Zegeye, Christopher M. Rose, Mike Reichelt, Man-Wah Tan. A microbiota-derived bile acid modulates biofilm formation by the probiotic strain Escherichia coli Nissle 1917. npj Biofilms and Microbiomes 2025; 11(1) doi: 10.1038/s41522-025-00854-z
201
Erica Bonazzi, Caterina De Barba, Greta Lorenzon, Daria Maniero, Luisa Bertin, Brigida Barberio, Federica Facciotti, Flavio Caprioli, Franco Scaldaferri, Fabiana Zingone, Edoardo Vincenzo Savarino. Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy. Expert Review of Gastroenterology & Hepatology 2025; 19(5) doi: 10.1080/17474124.2025.2495087
202
Jessica M. Till, Orion D. Brock, Elyza A. Do, Morgan J. Engelhart, Robert W. P. Glowacki, Shaomin Hu, Ansel Hsiao, Ina Nemet, Philip P. Ahern. Variation in Microbiome Composition and Faecal Metabolites Are Associated With Differential Susceptibility to DSS‐Induced Colitis. Immunology 2026; 177(4) doi: 10.1111/imm.70071
203
Jing Zhang, Ziquan Liu, Shanjun Song, Junkai Fang, Lei Wang, Lei Zhao, Chenguang Li, Weixia Li, Hyang-Min Byun, Liqiong Guo, Penghui Li. The exposure levels and health risk assessment of antibiotics in urine and its association with platelet mitochondrial DNA methylation in adults from Tianjin, China: A preliminary study. Ecotoxicology and Environmental Safety 2022; 231 doi: 10.1016/j.ecoenv.2022.113204
204
J.E. Vazquez Bucheli, S.D. Todorov, W.H. Holzapfel. Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders. Beneficial Microbes 2022; 13(4) doi: 10.3920/BM2022.0022
205
Alexander M Oberc, Aline A Fiebig-Comyn, Caressa N Tsai, Wael Elhenawy, Brian K Coombes. Antibiotics Potentiate Adherent-InvasiveE. coliInfection and Expansion. Inflammatory Bowel Diseases 2019; 25(4) doi: 10.1093/ibd/izy361
206
Toshifumi Osaka, Eri Moriyama, Shunichi Arai, Yasuhiro Date, Junji Yagi, Jun Kikuchi, Satoshi Tsuneda. Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases. Nutrients 2017; 9(12) doi: 10.3390/nu9121329
207
叶卿 罗. Research Progress of Relapse Factors in Inflammatory Bowel Disease. Advances in Clinical Medicine 2022; 12(07) doi: 10.12677/ACM.2022.127924
208
Rachel E Andrew, Evangelos Messaris. Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?. World Journal of Gastrointestinal Surgery 2016; 8(9): 598-605 doi: 10.4240/wjgs.v8.i9.598
209
Kaiyuan Yu, Qiang Tang, Zhi Yao, Quan Wang. A mouse model to test the anti-inflammatory effect of facultative anaerobes on dextran sulfate sodium-induced colitis. STAR Protocols 2023; 4(1) doi: 10.1016/j.xpro.2022.101988
210
Rinaldo Pellicano, Giovanni C Actis. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017; 8(2): 114-119 doi: 10.4292/wjgpt.v8.i2.114
211
Shatakshi Sharma, Sunil Kumar, Sheeral Sajjad, Samriddhi Sharma. Probiotics in Irritable Bowel Syndrome: A Review Article. Cureus 2023;  doi: 10.7759/cureus.36565
212
Dong Wook Shin, Beong Ou Lim. Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease. Journal of Medicinal Food 2020; 23(11) doi: 10.1089/jmf.2020.4712
213
Tedi Hoxha, Michael Youssef, Vivian Huang, Parul Tandon. Inflammatory Bowel Disease and Breastfeeding: A Narrative Review. Inflammatory Bowel Diseases 2025; 31(1) doi: 10.1093/ibd/izae033
214
Zachary White, Ivan Cabrera, Isabel Kapustka, Teruyuki Sano. Microbiota as key factors in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1155388
215
Jonathan D Schepper, Fraser Collins, Naiomy Deliz Rios-Arce, Ho Jun Kang, Laura Schaefer, Joseph D Gardinier, Ruma Raghuvanshi, Robert A Quinn, Robert Britton, Narayanan Parameswaran, Laura R McCabe. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced Osteoporosis. Journal of Bone and Mineral Research 2020; 35(4) doi: 10.1002/jbmr.3947
216
Adeola Temitope Salami, Gloria Enevwo Okotie, Precious Nekachi Echendu, Uwaifoh Akpamu, Samuel Babafemi Olaleye. Potassium bromate (KBrO3) modulates oxidative stress and inflammatory biomarkers in sodium hydroxide (NaOH) – induced Crohn’s colitis in Wistar rats. Canadian Journal of Physiology and Pharmacology 2021; 99(10) doi: 10.1139/cjpp-2020-0678
217
Giuseppe Gigliotti, Rashmi Joshi, Anam Khalid, David Widmer, Mariarosaria Boccellino, Davide Viggiano. Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease. International Journal of Molecular Sciences 2024; 25(16) doi: 10.3390/ijms25168592
218
Yanyan Wang, Luna Liu, Junming Han, Xiude Fan, Qingling Guo, Zhongming Wu. Evaluating the Impact of Obesity and Different Metabolic Statuses on the Prognosis of Hospitalized Patients with Inflammatory Bowel Disease: A Cohort Study. Obesity Facts 2023; 16(5) doi: 10.1159/000531994
219
Xianglu Ye, Miao Zhang, Ning Zhang, Hai Wei, Bing Wang. Gut-brain axis interacts with immunomodulation in inflammatory bowel disease. Biochemical Pharmacology 2024; 219 doi: 10.1016/j.bcp.2023.115949
220
Daya K. Jha, Shubhra Mishra, Usha Dutta, Vishal Sharma. Antibiotics for inflammatory bowel disease: Current status. Indian Journal of Gastroenterology 2024; 43(1) doi: 10.1007/s12664-024-01537-x
221
Andrew A Wood, Sophie Rothwell Mason, Anna F Robson. Metronidazole is a chromatographic interference on a routine HPLC-UV assay for thiopurine metabolites. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2025; 62(5) doi: 10.1177/00045632251319917
222
Sergio Álvarez-Pérez, Blanca Anega, José L. Blanco, Marta Hernández, Marta E. García. In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats. BMC Veterinary Research 2023; 19(1) doi: 10.1186/s12917-023-03801-2
223
Chuanfa Liu, Zhiming Li, Jiahong Ding, Hefu Zhen, Mingyan Fang, Chao Nie. Species-Level Analysis of the Human Gut Microbiome Shows Antibiotic Resistance Genes Associated With Colorectal Cancer. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.765291
224
Christy A Harrison, Daniel Laubitz, Monica T Midura-Kiela, Deepa R Jamwal, David G Besselsen, Fayez K Ghishan, Pawel R Kiela. Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis. Journal of Crohn's and Colitis 2019; 13(1) doi: 10.1093/ecco-jcc/jjy144
225
Tommaso Venneri, Giada Giorgini, Nadine Leblanc, Nicolas Flamand, Francesca Borrelli, Cristoforo Silvestri, Vincenzo Di Marzo. Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01823-1
226
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. Alenzi, Bedor A. Al-Omari, Hajer Y. Almudaiheem, Ahmed H. Al-Jedai, Mahmoud H. Mosli. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents. Saudi Journal of Gastroenterology 2025; 31(3) doi: 10.4103/sjg.sjg_171_24
227
Yoshihiro Miyagi, Tatsuya Kinjo, Tomoharu Yoshizumi, Noboru Harada, Shingo Arakaki, Tetsu Kinjo, Akira Hokama, Mitsuhisa Takatsuki. Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-01059-6
228
Kai Jiang, Xiangjing Cao, Haitao Wu, Yifeng Xu, Lulu Liu, Haisheng Qian, Zhaohua Miao, Hua Wang, Yan Ma. 2D Nanozymes Modulate Gut Microbiota and T‐Cell Differentiation for Inflammatory Bowel Disease Management. Advanced Healthcare Materials 2024; 13(4) doi: 10.1002/adhm.202302576
229
Livia Moreira Genaro, Julian Furtado Silva, Luis Eduardo Miani Gomes, Hugo Dugolin Ceccato, Amanda Pereira Lima, Maria de Lourdes Setsuko Ayrizono, Marciane Milanski Ferreira, Raquel Franco Leal. Natural Plant Products in Inflammatory Bowel Diseases. 2023;  doi: 10.1016/B978-0-323-99111-7.00013-1
230
Klára Szentmihályi, Szilvia Klébert, Zoltán May, Eszter Bódis, Miklós Mohai, László Trif, Tivadar Feczkó, Zoltán Károly. Immobilization of Metronidazole on Mesoporous Silica Materials. Pharmaceutics 2022; 14(11) doi: 10.3390/pharmaceutics14112332
231
Amir Hossein Barjasteh, Abdulridha Mohammed Al-Asady, Hanieh Latifi, Souad Al Okla, Nasser Al-Nazwani, Amir Avan, Majid Khazaei, Mikhail Ryzhikov, Hanieh Nadi-Yazdi, Seyed Mahdi Hassanian. Maximizing Treatment Options for IBD through Drug Repurposing. Current Pharmaceutical Design 2024; 30(32) doi: 10.2174/0113816128318032240702045822
232
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. Biomedicine & Pharmacotherapy 2023; 165 doi: 10.1016/j.biopha.2023.114893
233
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review. Reproductive Medicine 2023; 4(3) doi: 10.3390/reprodmed4030017
234
Peilin Yu, Yuanming Jin, Da-Jeong Park, Mingzhu Wang, Chong-Su Cho, Chunri Yan, Fuliang Sun, Xin Jin, Keesun Yu, Young Jin Pyung, Cheol-Heui Yun, Lianhua Cui. Lactobacillus acidophilus combined with Pediococcus acidilactici ameliorates colitis. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1773197
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.